Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems.
Nayoung HanJung Mi OhIn-Wha KimPublished in: Therapeutics and clinical risk management (2021)
The numbers of reported AEs with off-label drug increased annually. AEs associated with off-label drugs may have a significant impact on older patients. Healthcare experts should be concerned about prescriptions of off-label drugs, especially anticoagulants and newly developed drugs such as immunosuppressants and antineoplastic agents.